Technology development for single-molecule protein sequencing and single-cell proteome analysis (R01 clinical trial not allowed)
Summary text: This supports advances in single-molecule protein sequencing and single cell proteome analysis through technology development. Each grant is worth up to USD 500,000 in direct costs per year, for a maximum of three years.